{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:50:32Z","timestamp":1793260232913,"version":"4.5.0"},"reference-count":14,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Clinical practice guidelines recommend initiation of anticoagulation within 2 weeks after stroke with atrial fibrillation. It is unknown whether there is an optimal starting day within the 14-day period that balances the risks of recurrent embolic events against serious hemorrhagic events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine if there is an optimal delay time to initiate treatment with a direct oral anticoagulant after atrial fibrillation\u2013related stroke that minimizes the risk of a composite outcome of ischemic or hemorrhagic events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This phase 2, pragmatic, response-adaptive randomized clinical trial was conducted between June 2017 and June 2023 at acute care hospitals in Texas and included patients who had a mild to moderate ischemic stroke (minimum lesion diameter of 1.5 cm) with atrial fibrillation and were prescribed a direct oral anticoagulant within 2 weeks from stroke onset.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>Within 3 to 4 days after atrial fibrillation\u2013associated ischemic stroke, patients were randomized to a group for treatment start date (group 1 was day 3 or 4 after stoke onset; group 2 was day 6; group 3 was day 10; and group 4 was day 14) with a direct oral anticoagulant for secondary stroke prevention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The composite primary outcome was an ischemic (stroke or systemic embolism) or hemorrhagic (symptomatic intracranial hemorrhage or major systemic hemorrhage) event observed within 30 days from the index stroke time of onset. Posterior probabilities were used to estimate which timing groups were optimal for treatment initiation and were recalculated at predefined intervals. The randomization allocations were adjusted to favor the groups with higher probabilities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The trial enrolled and randomized 200 patients (50% were female; the median age was 75 years [IQR, 65-81 years]; 17.5% were Asian, Black, or &amp;amp;gt;1 race; 16.5% were Hispanic; the median National Institutes of Health Stroke Scale score was 6.5 [IQR, 4-14]; and the median lesion diameter was 3.1 cm [IQR, 2.0-4.4 cm]). No ischemic events were observed for group 1, 3 events were observed for group 2, 2 events were observed for group 3, and 2 events were observed for group 4. One hemorrhagic event was observed for group 1, 1 event was observed for group 2, 1 event was observed for group 3, and 0 events were observed for group 4. Group 1 had a posterior probability of 0.41 for being the optimal day for treatment initiation and it was 0.26 for group 2, 0.17 for group 3, and 0.15 for group 4. The use of response-adaptive randomization was feasible and favored groups with earlier initiation times for use of a direct oral anticoagulant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>A clearly superior day to initiate use of a direct oral anticoagulant for secondary stroke prevention in patients with atrial fibrillation was not identified, but the evidence suggests that initiating use of a direct oral anticoagulant earlier is better than at later times within the first 2 weeks after stroke onset.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT03021928?id=NCT03021928&amp;amp;amp;rank=1\">NCT03021928<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaneurol.2025.0285","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T15:56:43Z","timestamp":1743436603000},"page":"470","source":"Crossref","is-referenced-by-count":37,"title":["Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation"],"prefix":"10.1001","volume":"82","author":[{"given":"Steven J.","family":"Warach","sequence":"first","affiliation":[{"name":"Dell Medical School, University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Davis","sequence":"additional","affiliation":[{"name":"Dell Medical School, University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Dell Medical School, University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Gajewski","sequence":"additional","affiliation":[{"name":"Kansas University Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Wick","sequence":"additional","affiliation":[{"name":"Kansas University Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Shi","sequence":"additional","affiliation":[{"name":"Kansas University Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ty T.","family":"Shang","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaiWai M.","family":"Olson","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidarrth","family":"Prasad","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Birnbaum","sequence":"additional","affiliation":[{"name":"UT Health Science Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody M.","family":"Richardson","sequence":"additional","affiliation":[{"name":"UT Health Science Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean I.","family":"Savitz","sequence":"additional","affiliation":[{"name":"Stroke Institute, UT Health, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"UT Health Science Center, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Cruz-Flores","sequence":"additional","affiliation":[{"name":"Texas Tech University Health Sciences Center, El Paso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Alba","sequence":"additional","affiliation":[{"name":"Texas Tech University Health Sciences Center, El Paso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Anderson","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethan P.","family":"Venkatasubba Rao","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"King","sequence":"additional","affiliation":[{"name":"Tilman J. Fertitta Family College of Medicine, University of Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne N.","family":"Dula","sequence":"additional","affiliation":[{"name":"Dell Medical School, University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truman J.","family":"Milling","sequence":"additional","affiliation":[{"name":"Dell Medical School, University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"noi250008r1","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"noi250008r2","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association.","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"2","key":"noi250008r3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","article-title":"Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"noi250008r4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","article-title":"Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.","volume":"18","author":"Seiffge","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9921","key":"noi250008r5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"noi250008r6","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.3390\/jcm11174981","article-title":"Early anticoagulation in patients with acute ischemic stroke due to atrial fibrillation: a systematic review and meta-analysis.","volume":"11","author":"Palaiodimou","year":"2022","journal-title":"J Clin Med"},{"issue":"9","key":"noi250008r8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/1747493019870651","article-title":"Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a pragmatic, response-adaptive, prospective randomized clinical trial.","volume":"14","author":"King","year":"2019","journal-title":"Int J Stroke"},{"issue":"4","key":"noi250008r9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"14","key":"noi250008r11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non\u2013vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study.","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"issue":"26","key":"noi250008r12","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation.","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"noi250008r13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2024.1450","article-title":"Early vs late anticoagulation in minor, moderate, and major ischemic stroke with atrial fibrillation: post hoc analysis of the ELAN randomized clinical trial.","volume":"81","author":"Goeldlin","year":"2024","journal-title":"JAMA Neurol"},{"issue":"10464","key":"noi250008r14","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(24)02197-4","article-title":"Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.","volume":"404","author":"Werring","year":"2024","journal-title":"Lancet"},{"key":"noi250008r7","volume-title":"Bayesian Adaptive Methods for Clinical Trials","author":"Berry","year":"2011"},{"key":"noi250008r10","unstructured":"Berry Consultants, LLC. Fixed and Adaptive Clinical Trial Simulator (FACTS): computer program. Accessed February 19, 2025. https:\/\/www.berryconsultants.com\/software\/facts\/"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2831918\/jamaneurology_warach_2025_oi_250008_1746814077.2744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:01:47Z","timestamp":1747062107000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2831918"}},"subtitle":["A Pragmatic, Response-Adaptive Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.0285","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}